Structure of Risdiplam
CAS No.: 1825352-65-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Risdiplam is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.
Synonyms: RG7916; RO7034067; RO703406
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1825352-65-5 |
Formula : | C22H23N7O |
M.W : | 401.46 |
SMILES Code : | O=C1C=C(C2=NN3C(C(C)=C2)=NC(C)=C3)N=C4N1C=C(N(C5)CCNC65CC6)C=C4 |
Synonyms : |
RG7916; RO7034067; RO703406
|
MDL No. : | MFCD31657372 |
InChI Key : | ASKZRYGFUPSJPN-UHFFFAOYSA-N |
Pubchem ID : | 118513932 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03040635 | Healthy Volunteers | Phase 1 | Completed | - | United States, California ... More >> Collaborative Neuroscience Network, Inc. Garden Grove, California, United States, 92845 Less << |
NCT02908685 | Muscular Atrophy, Spinal | Phase 2 Phase 3 | Active, not recruiting | July 12, 2020 | - |
NCT02633709 | Spinal Muscular Atrophy | Phase 1 | Completed | - | Netherlands ... More >> Pra International Group B.V Groningen, Netherlands, 9728 NZ Less << |
NCT03036501 | Healthy | Phase 1 | Completed | - | Netherlands ... More >> Pra International Group B.V Groningen, Netherlands, 9728 NZ Less << |
NCT02913482 | Muscular Atrophy, Spinal | PHASE2 | COMPLETED | 2023-12-22 | Stanford University Medical Ce... More >>nter, Palo Alto, California, 94304, United States|Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, Illinois, 60611, United States|Boston Childrens Hospital, Boston, Massachusetts, 02115, United States|Columbia University Medical Center; The Neurological Institute of New York, New York, New York, 10032, United States|UZ Gent, Gent, 9000, Belgium|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium|Chr de La Citadelle, Liège, 4000, Belgium|Instituto de Puericultura E Pediatria Martag?o Gesteira, Rio de Janeiro, RJ, CEP 21941-912, Brazil|Hospital das Clinicas - FMUSP_X; Neurologia, Sao Paulo, SP, 05403-000, Brazil|Peking University First Hospital, Beijing City, 100034, China|Children's Hospital of Fudan University, Shanghai, 201102, China|Clinical Medical Center Zagreb; University Hospital Rebro Department of Paediatrics, Zagreb, 10000, Croatia|Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique ? L?ESCALE, Bron, 69677, France|Hopital Armand Trousseau, Paris, 75571, France|IRCCS Ospedale Pediatrico Bambino Gesù; U.O. Malattie Neuromuscolari e Neurodegenerative, Roma, Lazio, 00165, Italy|Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile, Roma, Lazio, 00168, Italy|IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative, Genova, Liguria, 16147, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia, Milano, Lombardia, 20122, Italy|Fondazione IRCCS Istituto Neurologico ?Carlo Besta?; UO di Neurologia dello Sviluppo, Milano, Lombardia, 20133, Italy|Hyogo Medical University Hospital, Hyogo, 663-8501, Japan|Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk, 80-952, Poland|The Children?s Memorial Health Institute Department of Neurology and Epileptology, Warszawa, 04-730, Poland|Russian Children Neuromuscular Center of Veltischev, Moscow, Moskovskaja Oblast, 125412, Russian Federation|King Faisal Specialist Hospital and Research Centre Building, Riyadh, 11211, Saudi Arabia|Institute for Mother and Child Dr. Vukan Cupic, Belgrade, 11000, Serbia|Hospital Sant Joan De Deu, Esplugues De Llobregas, Barcelona, 08950, Spain|Hospital Universitari Vall d'Hebron; Area Genética Clínica y Molecular, Barcelona, 08035, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain|Universit?ts-Kinderspital (UKBB) Neurop?diatrie, Basel, 4005, Switzerland|Hacettepe University, School of Medicine; Pediatrics Department; Pediatrics Child Neurology Unit, Ankara, 06100, Turkey|Hospital Yeditepe University Kozyatagi; Pediatry, Atasehir- Istanbul, 34752, Turkey|Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology, Kharkov, 61068, Ukraine Less << |
NCT03032172 | Spinal Muscular Atrophy | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-02-25 | Stanford University Medical Ce... More >>nter, Palo Alto, California, 94304, United States|Nemours Children's Hospital, Orlando, Florida, 32827, United States|Boston Childrens Hospital, Boston, Massachusetts, 02115, United States|Columbia University Medical Center, New York, New York, 10032, United States|UZ Gent, Gent, 9000, Belgium|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium|Hopital Femme Mere Enfant, Bron, 69677, France|Hopital Roger Salengro, Lille, 59037, France|CHRU de Montpellier, Hopital Gui de Chauliac, Montpellier, 34295, France|H?pital Necker-Enfants Malades, Paris, 75015, France|Hopital des Enfants, Toulouse, 31059, France|Universit?tsklinikum Essen, Essen, 45147, Germany|Universit?tsklinikum Freiburg, Freiburg, 79106, Germany|IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Lazio, 00165, Italy|Policlinico Agostino Gemelli, Roma, Lazio, 00168, Italy|IRCCS Istituto Giannina Gaslini, Genova, Liguria, 16147, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Lombardia, 20122, Italy|UOSD Malattie Neurodegenerative, Messina, Sicilia, 98125, Italy|UMC Utrecht, Utrecht, 3584 CX, Netherlands|Klinika Neurologii I Wydzialu Lekarskiego WUM w Warszawie, Warszawa, 02-097, Poland|Universit?ts-Kinderspital (UKBB) Neurop?diatrie, Basel, 4005, Switzerland|Birmingham Heartlands Hospital, Birmingham, B9 5SS, United Kingdom|UCL Institute of Child Health & Great Ormond Street Hospital for Children, London, WC1N 1EH, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, United Kingdom Less << |
NCT04256265 | Muscular Atrophy, Spinal | APPROVED_FOR_MARKETING | - | Arkansas Children's Hospital; ... More >>Pediatrics, Little Rock, Arkansas, 72202, United States|Children's Hospital Los Angeles, Los Angeles, California, 90010, United States|Stanford University, Palo Alto, California, 94304, United States|University of Colorado in Denver-Anschutz Medical Campus, Aurora, Colorado, 80045, United States|Nemours Children's Hospital, Orlando, Florida, 32827, United States|Comprehensive NeuroBehavioral Institute, Plantation, Florida, 33317, United States|Rare Disease Research, LLC, Atlanta, Georgia, 30318, United States|Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, Illinois, 60611, United States|Southern Illinois University, School of Medicine, Springfield, Illinois, 62702, United States|Indiana Hemophilia & Thrombosis center, Indianapolis, Indiana, 46260, United States|University of Iowa, Iowa City, Iowa, 52242, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Massachusetts General Hospital; Neurology, Boston, Massachusetts, 02114, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, 49503, United States|University of Mississippi Medical Center; Neurology, Jackson, Michigan, 39216, United States|Gillette Spcl Children's Clin; Pediatric Endocrinology, Saint Paul, Minnesota, 55101, United States|St. Louis Children Hospital, Saint Louis, Missouri, 63110, United States|Goryeb Children's Hospital, Morristown, New Jersey, 07960, United States|Northwell Hospital, New Hyde Park, New York, 11042, United States|NYU Langone, New York, New York, 10003, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States|Akron Childrens Hospital, Akron, Ohio, 44308, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|University of Virginia Children's Hospital; Developmental, Charlottesville, Virginia, 22903, United States|University of Wisconsin American Family; Childrens Hospital, Madison, Wisconsin, 53792, United States|Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, 53201, United States|Medical College of Wisconsin, Inc., Milwaukee, Wisconsin, 53226-3596, United States Less << | |
NCT05808764 | Muscular Atrophy, Spinal | PHASE2 | RECRUITING | 2025-08-31 | Ann and Robert H. Lurie Childr... More >>en Hospital of Chicago, Chicago, Illinois, 60611, United States|University Of Michigan, Ann Arbor, Michigan, 48109, United States|Clinic for Special Children., Gordonville, Pennsylvania, 17529, United States|Hopital Universitaire des Enfants Reine Fabiola, Bruxelles, 1020, Belgium|CHR Citadelle, Liege, 4000, Belgium|Children'S Hospital of Eastern Ontario, Ottawa, Ontario, K1H 8L1, Canada|Universitatsklinikum Essen, Essen, 45147, Germany|Fondazione Serena Onlus - CENTRO CLINICO NEMO, Milano, Emilia-Romagna, 20162, Italy|Fondazione Policlinico Univeristario A. Gemelli, Roma, Emilia-Romagna, 00168, Italy|UMC Utrecht, Utrecht, 3508, Netherlands|OUS (Oslo University Hospital), Rikshospitalet, Oslo, 0372, Norway|Uniwersyteckie Centrum Kliniczne, Gda?sk, 80-952, Poland|Instytut Pomnik - Centrum Zdrowia Dziecka, Warszawa, 04-730, Poland Less << |
NCT03779334 | Muscular Atrophy, Spinal | PHASE2 | ACTIVE_NOT_RECRUITING | 2027-03-31 | Nemours Children's Hospital, O... More >>rlando, Florida, 32827, United States|Sydney Children's Hospital; CENTRE FOR CHILD HEALTH RESEARCH & INNOVATION (CHeRI), Randwick, New South Wales, 2031, Australia|Chr de La Citadelle, Liège, 4000, Belgium|Hospital das Clinicas - FMUSP_X; Neurologia, Sao Paulo, SP, 05403-000, Brazil|Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk, 80-952, Poland|Russian Children Neuromuscular Center of Veltischev, Moscow, Moskovskaja Oblast, 125412, Russian Federation|Kaohsiung Medical University Chung-Ho Hospital; Pediatric Neurology, Kaohsiung, 807, Taiwan Less << |
NCT05522361 | Spinal Muscular Atrophy | PHASE4 | ACTIVE_NOT_RECRUITING | 2026-06-15 | Clinic for Special Children, S... More >>trasburg, Pennsylvania, 17579, United States Less << |
NCT05219487 | Spinal Muscular Atrophy | RECRUITING | 2025-12-31 | The Ohio State University Wexn... More >>er Medical Center, Columbus, Ohio, 43210, United States Less << | |
NCT03920865 | Muscular Atrophy, Spinal | PHASE1 | COMPLETED | 2020-01-02 | Clinical Pharmacology of Miami... More >>, Inc., Miami, Florida, 33014, United States|Orlando Clinical Research Center, Orlando, Florida, 32809, United States|American Research Corporation Inc., San Antonio, Texas, 78215, United States Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.49mL 0.50mL 0.25mL |
12.45mL 2.49mL 1.25mL |
24.91mL 4.98mL 2.49mL |
Tags: Risdiplam | RG7916 | Spiroes | DNA/RNA Synthesis | Heterocyclic Building Blocks | Tumor Epigenetics and Gene Regulation | Cell Cycle | DNA Damage | 1825352-65-5
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL